DXRX Insider Trading

Insider Ownership Percentage: 34.54%
Insider Buying (Last 12 Months): £84,896.95
Insider Selling (Last 12 Months): £765,000

Diaceutics Insider Trading History Chart

This chart shows the insider buying and selling history at Diaceutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Diaceutics Share Price & Price History

Current Price: GBX 131.06
Price Change: Price Increase of +0.055 (0.04%)
As of 07/24/2024 12:44 PM ET

This chart shows the closing price history over time for DXRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Diaceutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/28/2024Nick RobertsInsiderBuy122GBX 1GBX 122
5/22/2024Graham PatersonInsiderBuy39,934GBX 129£51,514.86
3/28/2024Peter KeelingInsiderSell750,000GBX 102£765,000
3/6/2024Graham PatersonInsiderBuy33,564GBX 99£33,228.36
1/30/2024Nick RobertsInsiderBuy152GBX 1GBX 152
10/27/2023Nick RobertsInsiderBuy170GBX 88£149.60
8/29/2023Nick RobertsInsiderBuy139GBX 1GBX 139
6/5/2023Nick RobertsInsiderBuy21,742GBX 92£20,002.64
5/30/2023Nick RobertsInsiderBuy183GBX 82£150.06
2/28/2023Nick RobertsInsiderBuy130GBX 115£149.50
1/27/2023Nick RobertsInsiderBuy153GBX 98£149.94
12/29/2022Nick RobertsInsiderBuy198GBX 1GBX 198
10/28/2022Nick RobertsInsiderBuy181GBX 1GBX 181
9/9/2022Nick RobertsInsiderBuy161GBX 93£149.73
4/6/2022Deborah DavisInsiderBuy5,000GBX 102£5,100
9/27/2021Deborah DavisInsiderBuy17,800GBX 111£19,758
See Full Table

SEC Filings (Institutional Ownership Changes) for Diaceutics (LON:DXRX)

53.14% of Diaceutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Diaceutics logo
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Read More on Diaceutics

Today's Range

Now: GBX 131.06
Low: 130
High: 131.50

50 Day Range

MA: GBX 126.41
Low: 104
High: 134

52 Week Range

Now: GBX 131.06
Low: 82
High: 136

Volume

296,879 shs

Average Volume

106,041 shs

Market Capitalization

£110.65 million

P/E Ratio

10,500.00

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of Diaceutics?

Diaceutics' top insider investors include:
  1. Graham Paterson (Insider)
  2. Nick Roberts (Insider)
  3. Peter Keeling (Insider)
Learn More about top insider investors at Diaceutics.